These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23665798)

  • 1. Coumarin chalcone fibrates: a new structural class of lipid lowering agents.
    Sashidhara KV; Palnati GR; Sonkar R; Avula SR; Awasthi C; Bhatia G
    Eur J Med Chem; 2013 Jun; 64():422-31. PubMed ID: 23665798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
    Sashidhara KV; Dodda RP; Sonkar R; Palnati GR; Bhatia G
    Eur J Med Chem; 2014 Jun; 81():499-509. PubMed ID: 24871900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents.
    Sashidhara KV; Palnati GR; Dodda RP; Sonkar R; Khanna AK; Bhatia G
    Eur J Med Chem; 2012 Nov; 57():302-10. PubMed ID: 23078966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies.
    Niu H; Wang W; Li J; Lei Y; Zhao Y; Yang W; Zhao C; Lin B; Song S; Wang S
    Eur J Med Chem; 2017 Sep; 138():212-220. PubMed ID: 28667876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid benzofuran-bisindole derivatives: new prototypes with promising anti-hyperlipidemic activities.
    Sashidhara KV; Modukuri RK; Sonkar R; Rao KB; Bhatia G
    Eur J Med Chem; 2013 Oct; 68():38-46. PubMed ID: 23954239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation.
    Hassan RM; Aboutabl ME; Bozzi M; El-Behairy MF; El Kerdawy AM; Sampaolese B; Desiderio C; Vincenzoni F; Sciandra F; Ghannam IAY
    Bioorg Chem; 2021 Oct; 115():105170. PubMed ID: 34332233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents.
    Sashidhara KV; Kumar A; Kumar M; Sarkar J; Sinha S
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7205-11. PubMed ID: 21071221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological evaluation of chalcones and analogues as hypolipidemic agents.
    Santos L; Curi Pedrosa R; Correa R; Cechinel Filho V; Nunes RJ; Yunes RA
    Arch Pharm (Weinheim); 2006 Oct; 339(10):541-6. PubMed ID: 17009298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives.
    Sashidhara KV; Kumar A; Kumar M; Srivastava A; Puri A
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6504-7. PubMed ID: 20932744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic activity of Achyranthus aspera Linn in normal and triton induced hyperlipemic rats.
    Khanna AK; Chander R; Singh C; Srivastava AK; Kapoor NK
    Indian J Exp Biol; 1992 Feb; 30(2):128-30. PubMed ID: 1521862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin potentially attenuates cadmium induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.
    Milton Prabu S; Muthumani M; Shagirtha K
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):582-95. PubMed ID: 23543441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidative and lipid lowering effects of 7,8-dihydroxy-3- (4-methylphenyl) coumarin in hyperlipidemic rats.
    Yuce B; Danis O; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2009; 59(3):129-34. PubMed ID: 19402343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate.
    Shattat G; Al-Qirim T; Sweidan K; Shahwan M; El-Huneidi W; Al-Hiari Y
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):751-5. PubMed ID: 20590406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel coumarin derivatives as potential antidyslipidemic agents.
    Sashidhara KV; Kumar A; Kumar M; Sonkar R; Bhatia G; Khanna AK
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4248-51. PubMed ID: 20542691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of coumarin and some coumarin derivatives on serum lipid profiles in carbontetrachloride-exposed rats.
    Taşdemir E; Atmaca M; Yıldırım Y; Bilgin HM; Demirtaş B; Obay BD; Kelle M; Oflazoğlu HD
    Hum Exp Toxicol; 2017 Mar; 36(3):295-301. PubMed ID: 27185181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antidyslipidemic activity of chalcone fibrates.
    Shukla P; Srivastava SP; Srivastava R; Rawat AK; Srivastava AK; Pratap R
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3475-8. PubMed ID: 21515043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidyslipidemic and antioxidant effects of novel Lupeol-derived chalcones.
    Srivastava S; Sonkar R; Mishra SK; Tiwari A; Balaramnavar VM; Mir S; Bhatia G; Saxena AK; Lakshmi V
    Lipids; 2013 Oct; 48(10):1017-27. PubMed ID: 23943005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoproteins in streptozotocin-diabetic rats, after Triton WR-1339 treatment.
    Takahashi K; Murase T; Yamada N; Iwamoto Y; Akanuma Y; Takaku F
    Horm Metab Res; 1984 Dec; 16 Suppl 1():82-4. PubMed ID: 6532938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies.
    Birari RB; Gupta S; Mohan CG; Bhutani KK
    Phytomedicine; 2011 Jun; 18(8-9):795-801. PubMed ID: 21315569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.